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INTRODUCTION
Resistance exercise training is widely used to enhance general itness 
and athletic potential/capacity across many sporting disciplines in-
cluding power, strength and endurance events [1, 2]. When prop-
erly performed and combined with adequate nutrition, resistance 
training leads to increases in strength, power, speed, muscle size, 
local muscular endurance, coordination, and lexibility and reductions 
in body fat and blood pressure [3].
Effective resistance exercise prescription involves manipulation 
of several variables speciic to the targeted goals, such as intensity 
or load per repetition (i.e. percentage of one repetition maxi-
A genetic-based algorithm for personalized resistance training
AUTHORS: Jones N1, Kiely J2, Suraci B3, Collins DJ2, de Lorenzo D4,5, Pickering C6, Grimaldi KA6
1  DNA Sports Performance Ltd, Manchester, UK 
2  Institute of Coaching and Performance, University of Central Lancashire, Preston, UK
3  Suraci Consultancy, Portsmouth, UK 
4  Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, CEXS-UPF-PRBB, Barcelona, 
Catalonia, Spain
5  Centro de Estudios en Genómica y Nutrición-CESGEN, Parc Cientíic i Tecnològic Agroalimentari de Lleida-
PCiTAL, Lleida, Catalonia, Spain
6  Exercise and Nutritional Genomics Research Centre, DNAFit Ltd, London, UK
ABSTRACT: Association studies have identiied dozens of genetic variants linked to training responses and 
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genetic proile have been conducted. Here we propose an algorithm that allows achieving greater results in 
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athletes from different sports (n=28); study 2: soccer players (n=39)). In both studies athletes completed an 
eight-week high- or low-intensity resistance training program, which either matched or mismatched their 
individual genotype. Two variables of explosive power and aerobic itness, as measured by the countermovement 
jump (CMJ) and aerobic 3-min cycle test (Aero3) were assessed pre and post 8 weeks of resistance training. In 
study 1, the athletes from the matched groups (i.e. high-intensity trained with power genotype or low-intensity 
trained with endurance genotype) signiicantly increased results in CMJ (P=0.0005) and Aero3 (P=0.0004). 
Whereas, athletes from the mismatched group (i.e. high-intensity trained with endurance genotype or low-
intensity trained with power genotype) demonstrated non-signiicant improvements in CMJ (P=0.175) and less 
prominent results in Aero3 (P=0.0134). In study 2, soccer players from the matched group also demonstrated 
signiicantly greater (P<0.0001) performance changes in both tests compared to the mismatched group. Among 
non- or low responders of both studies, 82% of athletes (both for CMJ and Aero3) were from the mismatched 
group (P<0.0001). Our results indicate that matching the individual’s genotype with the appropriate training 
modality leads to more effective resistance training. The developed algorithm may be used to guide individualised 
resistance-training interventions.
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mum (1 RM)), volume (total number of sets and repetitions), train-
ing frequency, muscle action (concentric vs. eccentric), rest intervals 
between sets, repetition velocity and others [3, 4]. Furthermore, 
resistance training can be categorized into two common types: low-
intensity (~30% of 1 RM and high repetitions) and high-intensity 
(~70% of 1 RM and low repetitions) resistance training. Low-in-
tensity resistance training is effective for increasing absolute local 
muscular endurance [5], explosive power [6, 7] and preferential 
hypertrophy of slow-twitch muscle ibres [8, 9], while high-intensi-
ty training (also known as classic strength training) leads to in-
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creases in absolute strength [3] and the hypertrophy of all types of 
muscle ibres [10, 11].
There is a large variability in both muscle size and strength gains 
in response to resistance training between individuals [4]. In a large 
study of 585 subjects, Hubal et al. [12] have shown that men and 
women exhibited wide ranges of strength gain (1 RM: 0 to +250%) 
and skeletal muscle hypertrophy (cross-sectional area: -2 to +59%) 
in response to 12 weeks of resistance training, indicating individual 
training responses may vary widely dependent on factors such as 
genetic heritage. Accordingly, the level of adaptation experienced by 
each individual will be dependent on the interaction between spe-
ciic training performed and genotype. Indeed, there is a general 
consensus that resistance training programs should be individualized, 
but little information exists to accurately discern how best to person-
alize training program design to maximize outcomes [3, 4, 12, 13]. 
Muscle iber composition is a heritable (~45%) trait [14], with 
large variability between individuals. For example, slow-twitch (Type I) 
content of vastus lateralis ranges from 5-90%. This variability, in 
turn, may determine individual’s potential to perform different types 
of resistance training. Accordingly, data show that Type I muscle 
Gene Full name Functions and associated phenotypes Polymorphism Endurance or power 
related allele
References
ACE Angiotensin I 
converting enzyme
Regulates circulatory homeostasis through 
the synthesis of vasoconstrictor angiotensin II 
and the degradation of vasodilator kinins.
Alu I/D 
(rs4646994)
Endurance: I
Power: D
[20, 21]
ACTN3 α-actinin-3 Stabilizes the muscle contractile apparatus in fast-twitch muscle ibres. Arg577Ter (rs1815739 C/T) Endurance: 577Ter (T) Power: Arg577 (C)
[20, 22]
ADRB2 β-2 adrenoreceptor Plays a pivotal role in the regulation of the 
cardiac, pulmonary, vascular, endocrine and 
central nervous system.
Gly16Arg (rs1042713 G/A) Endurance: 16Arg (A) [23, 24]
Gln27Glu (rs1042714 C/G) Endurance: Gln27 (C) [25]
AGT Angiotensinogen Angiotensinogen is an essential component of the renin-angiotensin system that regulates 
vascular resistance and sodium homeostasis, 
and thus determining blood pressure.
Met235Thr (rs699 T/C) Power: 235Thr (C) [26, 27]
BDKRB2 Bradykinin receptor 
B2
Involved in the endothelium-dependent 
vasodilation.
rs1799722 C/T Endurance: T [24]
COL5A1 Collagen, type V, α1 Encodes the pro-α1 chain of type V collagen, the rate-limiting component of the of type V 
collagen trimer assembly.
rs12722 C/T 
(BstUI)
Endurance: T [28, 29]
CRP C-reactive protein, pentraxin-related Involved in several host defense related functions based on its ability to recognize 
damaged cells and to initiate their elimination 
in the blood.
rs1205 A/G Endurance: A [30, 31]
GABPB1 
(NRF2)
GA binding protein 
transcription factor, β subunit 1 (nuclear 
respiratory factor 2)
Encodes a transcriptional regulator of 
genes involved in activation of cytochrome 
oxidase expression and nuclear control of 
mitochondrial function.
rs7181866 A/G Endurance: G [32, 33]
IL6 Interleukin-6 IL-6 is a pleiotropic cytokine expressed in 
immune and muscle cells. Involved in a 
wide variety of biological functions, including 
regulation of differentiation, proliferation and 
survival of target cells.
-174 C/G 
(rs1800795)
Power: G [34, 35]
PPARA Peroxisome proliferator-activated receptor α
Regulates liver, heart and skeletal muscle 
lipid metabolism, glucose homeostasis, 
mitochondrial biogenesis, cardiac 
hypertrophy.
rs4253778 G/C Endurance: G Power: C [36, 37]
PPARGC1A Peroxisome proliferator-activated receptor γ coactivator 1 α
Regulates fatty acid oxidation, glucose 
utilization, mitochondrial biogenesis, 
thermogenesis, angiogenesis, formation of muscle ibers.
Gly482Ser 
(rs8192678 G/A)
Endurance: Gly482 (G) [38, 39]
TRHR Thyrotropin-
releasing hormone 
receptor
Stimulates the release of thyroxine, which is 
important in developing skeletal muscle.
rs16892496 A/C Power (muscle mass): C [40]
VDR Vitamin D receptor Involved in sustaining normocalcemia by 
inhibiting the production of parathyroid 
hormone and has effects on bone and 
skeletal muscle biology.
BsmI A/G 
(rs1544410)
Power: A [41, 42]
VEGFA Vascular endothelial 
growth factor A
Growth factor active in angiogenesis, 
vasculogenesis and endothelial cell growth.
rs2010963 G/C Endurance: C [43, 44]
TABLE 1. List of genetic variants analysed by DNAFit Peak Performance Algorithm™
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ibres have high resistance to fatigue and are thus suited for low-
intensity resistance or aerobic (endurance) training, IIA ibres are 
better suited for medium-term anaerobic exercise, and type IIX 
ibres are adapted for high-intensity (power and strength) exer-
cise [8, 13, 15]. It should be noted that although muscle ibre 
composition is an informative biomarker, muscle biopsies are 
highly invasive. Subsequently, the potential value of non-invasive 
exercise prescription tools, such as genetic proiling, seems worthy 
of investigation. 
Association studies have linked dozens of genetic variants to train-
ing responses and sport-related traits, such as strength, skeletal 
muscle mass, recovery ability and muscle ibre composition [16-19]. 
However, no intervention studies prescribing training on the basis of 
a genetic proile of athletes have been carried out. Here we evaluate 
an algorithm that facilitates training prescription by using a panel of 
15 gene polymorphisms associated with physical performance and 
muscle-speciic traits to predict an athlete’s potential for development 
of power and/or endurance qualities (Table 1). These polymorphisms 
are located within the genes involved in the regulation of muscle 
ibre type composition and muscle size, cytoskeletal function, mus-
cle damage protection, metabolism, circulatory homeostasis, mito-
chondrial biogenesis, thermogenesis and angiogenesis. 
The aim of the present work therefore was to test, in two inde-
pendent studies, the hypothesis that genetically matched athletes 
(i.e. high-intensity trained with power genotype or low-intensity 
trained with endurance genotype) show greater improvements in 
explosive power (countermovement jump) and aerobic itness (aero-
bic 3-min cycle test) in response to high- or low-intensity resistance 
training compared to mismatched athletes (i.e. high-intensity trained 
with endurance genotype or low-intensity trained with power geno-
type).
MATERIALS AND METHODS 
Study participants. In Study 1, 55 Caucasian male University ath-
letes, all aged 18-20 years, volunteered for the study, and 28 of them 
(height 180.7 ± 1.5 cm, weight 77.0 ± 2.1 kg) successfully com-
pleted it (27 athletes had not completed all aspects of the study due 
to either injury or illness). Each participant was a member of irst or 
second team, actively competing in British Universities and Colleges 
Sports (BUCS) leagues. The athletes competed in squash (n = 1), 
swimming (n = 7), running (n = 1), ski/snowboard (n = 4), soccer 
(n = 1), lacrosse (n = 2), badminton (n = 1), motorsport (n = 1), 
cycling (n = 4), cricket (n = 2), volleyball (n = 1), fencing (n = 1) 
and rugby union (n = 2).
In study 2, 68 male soccer players, all aged 16-19 years, volun-
teered to participate in the study, and 39 of them (height 176.1 ± 
1.0 cm, weight 68.9 ± 1.5 kg) successfully completed it (29 par-
ticipants were withdrawn from the study due to non-adherence of 
set training volumes over the 8 weeks, or injury). Each subject was 
a member of college soccer academy who actively competed in BUCS 
leagues.
Ethical approval
The two-stage study was approved by the University of Central Lan-
cashire Ethics Committee according to the Declaration of Helsinki. 
Each participant gave written informed consent after procedures were 
fully explained. Each participant was free to withdraw from the stud-
ies at anytime.
Study design
Study design utilised a time series trial as explained by Batterham 
and Hopkins [45]. Participants of both studies were randomly allo-
cated to an eight-week high- or low-intensity resistance-training 
program, after undergoing performance tests for both explosive 
power and endurance. Participants transitioned from their normal 
training plan to the designed 8-week intervention followed by an 
eight-week wash-out period. The study was double blinded, in that 
all were unaware of their ‘genetic potential status’, as determined by 
the DNAFit Peak Performance Algorithm™. This also included the 
lead investigator who coached the participants during the 8 weeks 
of resistance training. 
Prior to involvement in the study, all participants had undertaken 
weekly strength and conditioning programs, supervised by an ac-
credited strength and conditioning coach, for a minimum of six months 
and maximum of two and half years. These sessions took place in a 
free weights facility where technique and adherence was closely 
monitored at all times. Participants engaged in a minimum of one, 
and maximum of two (preferentially), sessions per week. No other 
form of resistance training was undertaken during this time, and 
participants were actively partaking in other sport-speciic training 
sessions and competitive games in parallel to the intervention. The 
investigator selected the same exercises for both groups: deadlift, 
pulldowns, front squat to 90 degrees, dumbbell lat press, step ups 
to medium high box and vertical jump single effort.
Each group self-selected training loads for each session, were 
monitored for progressive increases in perceived exertion, using a 
modiied Borg scale, and loads were recorded to ensure progression. 
The only differences between the training programs were volume 
modiications. The high-intensity resistance training program con-
sisted of ten sets of two reps over the eight-week study. This gave a 
total volume of one hundred and twenty reps per session. The low-
intensity resistance training program consisted of three sets of ten 
reps for irst two weeks, three sets of ifteens reps for the next three 
weeks and three sets of twenty for the last three weeks. This gave a 
total volume of one hundred and eighty reps in the irst two weeks, 
two hundred and seventy in the next three weeks and three hundred 
and sixty reps in the last three weeks. 
Physiological measurements
All participants undertook a pre- and post-test measure of explosive 
power and aerobic itness (endurance performance); namely, a coun-
termovement jump (CMJ) and Aerobic 3-min Cycle test (Aero3), us-
ing a Optojump (Microgate, Italia) and Wattbike Pro (Wattbike, Not-
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tingham, UK), respectively. Participants performed a standardized 
warm up before every testing session with the CMJ preceding the 
Aero3. Subjects were requested to arrive for testing in a rested and 
hydrated state and to refrain from caffeine intake for at least 12 hours 
before testing. Testing took place on the same time and weekday on 
each occasion, to ensure a consistent placement within the subject’s 
usual schedule. 
Genotyping
Upon enrollment into study each participant volunteered a saliva 
sample, which was collected through sterile and self-administered 
buccal swabs. Samples were sent to IDna Genetics laboratory (Nor-
wich, UK) within thirty-six hours, where analysis of the genes detailed 
in Table 1 was undertaken. DNA was extracted and puriied using 
the Isohelix Buccalyse DNA extraction kit BEK-50 (Kent, UK). DNA 
samples were ampliied by real-time PCR on an ABI7900 real-time 
thermocycler (Applied Biosystem, Waltham, USA). 
Calculation of power/endurance ratio
Following the analysis, the DNAFit Peak Performance Algorithm™ 
was used to determine percentage power/endurance score (P/E) ra-
tio, similar to the research conducted by Egorova et al. [46]. Ini-
tially, each allele was given a point (0, 1, 2, 3 or 4) depending on 
the effect of the polymorphism on performance (power/muscle hy-
pertrophy or endurance with respect to response to training). The 
strength of the rating was based on the evidence from cumulative 
literature results averaged over time. The total points for the P/E were 
expressed as a percentage of P/E and then combined to give the 
balance percentage. A percentage-ranking list was then complied 
using this score. Every other participant on the list then undertook 
high- or low-intensity resistance training. To clarify, someone who is 
75% power but does low-intensity resistance training would be doing 
mismatched genotype training, while a participant rated as 75% 
endurance that completed low-intensity resistance training would be 
doing matched genotype training. A threshold for 50% was used as 
the splitting value in this process. 
Statistical analysis
Statistical analysis was conducted in SPSS, Version 20 (Chicago, IL). 
The required sample size for this study was validated using the Mann-
Whitney test. The chi-square test was used to test genotype distribu-
tions for deviation from Hardy-Weinberg equilibrium. The non-para-
metric 2-sample paired test was performed matching “before” and 
“after” measurements from each individual tested. A 2-sided Mann-
Whitney test for 2 independent samples was used to compare gains 
in CMJ and Aero3 between groups. Differences in phenotypes between 
different genotype groups were analysed using ANOVA or unpaired t 
test. Spearman’s (non-parametric) correlations were used to assess 
the relationships between the genotype score and performance tests. 
The squared correlation coeficient R2 was used as a measure of 
explained variance. Bonferroni’s correction for multiple testing was 
performed by multiplying the P value with the number of tests where 
appropriate. All data are presented as mean (standard deviation; SD). 
Statistical signiicance was set at a P value < 0.05. 
RESULTS 
Eiciency of diferent training modalities. All performance param-
eters increased signiicantly (<0.001) in response to low- and high-
intensity resistance training when the results of two studies were 
combined. No signiicant differences in explosive power (CMJ: 5.4 
(5.0) vs. 4.6 (6.1)%, P = 0.547) and aerobic itness (Aero3: 4.3 
(3.8) vs. 4.3 (3.7)%, P = 0.711) gains were observed between 
low- and high-intensity resistance training groups, indicating that i) 
both training modalities can be used to improve these performance 
parameters and ii) results of responses to both training types can be 
combined for the analysis where appropriate.
Association analysis between genotypes and phenotypes
With some exceptions for the GABPB1 and VDR gene polymorphisms 
in Study 2 (due to the low sample sizes in terms of population genet-
ics), genotype distributions of 15 gene polymorphisms amongst all 
athletes of both studies were in Hardy-Weinberg equilibrium (Table 2). 
To assess the association between each polymorphism and per-
formance parameters we used the combined data of two studies. 
After Bonferroni’s correction for multiple testing the results were 
considered signiicant with P < 0.0033 (i.e. 0.05/15). In accordance 
with the literature data (Table 1), we found that athletes with the 
ACE DD (P > 0.1 for CMJ, P > 0.1 for Aero3), ACTN3 Arg/Arg (P 
= 0.065 for CMJ, P = 0.0038 for Aero3), CRP rs1205 GG (P > 
0.1 for CMJ, P = 0.0833 for Aero3), PPARGC1A Ser/Ser (P = 
0.065 for CMJ, P = 0.0499 for Aero3) and VDR AA (P > 0.1 for 
CMJ, P > 0.1 for Aero3) genotypes demonstrated a tendency to 
have greater gains in one or two performance tests compared with 
the opposite genotype carriers after high-intensity resistance training, 
while the latter (except for the PPARGC1A polymorphism) better 
responded to the low-intensity training (ACE II: P > 0.1 for CMJ, 
P = 0.0355 for Aero3; ACTN3 Ter/Ter: P > 0.1 for CMJ, P > 0.1 
for Aero3; CRP rs1205 AA: P = 0.0224 for CMJ, P > 0.1 for Aero3; 
VDR GG (P > 0.1 for CMJ, P = 0.0311 for Aero3). No signiicant 
differences in CMJ and Aero3 gains were observed between different 
genotype groups with respect to the other polymorphisms (data not 
shown). However, given that the latter 10 polymorphisms have 
recently been reported to be associated with endurance, power and 
muscle-speciic traits, and the fact that each contributing gene can 
explain only a small portion of the observed interindividual differ-
ences in training-induced effects, we felt justiied in retaining all 15 
genetic markers for further analysis.  
Efect of diferent training modalities and genetic proiles on per-
formance parameters
Based on power/endurance genotype score (see Methods), in two 
studies we identiied 39 athletes (58.2%) with endurance genotype 
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and 28 athletes (41.8%) with power genotype proiles. Changes in 
CMJ and Aero3 tests of athletes with predominantly endurance or 
power genotype proiles from both studies after 8 weeks of low- and 
high-resistance training are presented in Tables 3 and 4. In both 
studies it was shown that athletes with endurance genotype proile 
had greater beneits from the low-intensity resistance training, while 
athletes with power genotype proile better responded to the high-
intensity resistance training. As expected, the outcomes were more 
prominent in the Study 2 with homogeneous cohort (i.e. soccer 
players). Furthermore, we found that power genotype score (%) of 
athletes from both studies was positively correlated with CMJ (r = 
0.56; P = 0.0005) and Aero3 (r = 0.39; P = 0.0199) increases 
(%) in response to high-intensity training, while endurance genotype 
score (%) was positively correlated with CMJ (r = 0.37; P = 0.0399) 
and Aero3 (r = 0.51; P = 0.0032) increases (%) in response to 
low-intensity training, indicating that power genotype score explained 
14-32% of the variation in physiological parameters of athletes.
In accordance with power/endurance genotype score and training 
modality, 34 athletes performed matched training (high-intensity 
training with power genotype (n=15) or low-intensity training with 
endurance genotype (n=19)), while other 33 athletes completed 
mismatched training (high-intensity training with endurance genotype 
(n=20) or low-intensity training with power genotype (n=13)). In 
study 1, the athletes from the matched group have signiicantly in-
creased their results in CMJ (P=0.0005) and Aero3 (P=0.0004). 
On the other hand, athletes from the mismatched group have shown 
non-signiicant improvements in CMJ (P=0.175) and less prominent 
results in Aero3 (P=0.0134) (Table 5). In study 2, soccer players 
from the matched group have also demonstrated signiicantly great-
er (P<0.0001) performance changes in both tests compared to 
mismatched group (Table 5). 
Determinants of variability in response to resistance training 
With respect to the changes in CMJ gains (%), the athletes from both 
studies (n = 67) were divided into tertiles: high responders (increase 
in CMJ from 7.4 to 19.4%; n = 23), moderate responders (increase 
Gene and variation Study Genotypes MAF, % PHW
AA AB BB
ACE rs4646994 I/D S1 DD 10 ID 11 II 7 I 44.6 0.2776
S2 14 16 9 43.6 0.3005
ACTN3 rs1815739 C/T S1 CC 8 CT 10 TT 10 T 53.6 0.1356
S2 12 21 6 42.3 0.5199
ADRB2 rs1042713 G/A S1 GG 16 GA 10 AA 2 A 25.0 0.8011
S2 21 13 5 29.5 0.2153
ADRB2 rs1042714 C/G S1 CC 5 CG 15 GG 8 G 55.4 0.6572
S2 14 16 9 43.6 0.3005
AGT rs699 T/C S1 TT 9 TC 15 CC 4 C 41.1 0.5723
S2 17 17 5 34.6 0.8171
BDKRB2 rs1799722 C/T S1 CC 9 CT 14 TT 5 T 42.9 0.9122
S2 15 17 7 39.7 0.5745
COL5A1 rs12722 C/T S1 TT 8 TC 17 CC 3 C  41.1 0.1784
S2 13 17 9 44.9 0.4576
CRP rs1205 A/G S1 GG 12 GA 12 AA 4 A 35.7 0.7243
S2 21 12 6 30.8 0.0828
GABPB1 rs7181866 A/G S1 AA 27 AG 1 GG 0 G 1.8 0.9233
S2 36 2 1 5.1 0.0031*
IL6 rs1800795 C/G S1 GG 10 GC 13 CC 5 C 41.1 0.8289
S2 17 16 6 35.9 0.4977
PPARA rs4253778 G/C S1 GG 21 GC 5 CC 2 C 16.1 0.0736
S2 26 11 2 19.2 0.5653
PPARGC1A rs8192678 G/A S1 GG 7 GA 18 AA 3 A 42.9 0.0982
S2 15 17 7 39.7 0.5745
TRHR rs16892496 A/C S1 AA 14 AC 9 CC 5 C 33.9 0.1342
S2 15 17 7 39.7 0.5745
VDR rs1544410 A/G S1 GG 11 GA 16 AA 1 A 32.1 0.1009
S2 16 11 12 44.9 0.0073*
VEGFA rs2010963 G/C S1 GG 13 GC 11 CC 4 C 33.9 0.5126
S2 18 18 3 30.8 0.6028
TABLE 2. Genotype distributions and minor allele frequencies of candidate genes in athletes of two studies.
Note: MAF - minor allele frequency; S1 - Study 1; S2 - Study 2. *PHW < 0.05 - not consistent with Hardy-Weinberg equilibrium.
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in CMJ from 2.7 to 7.2%; n = 22) and non- or low responders 
(increase in CMJ from -8.4 to 2.5%; n=22). There was a signiicant 
linear trend for the proportion of matched-trained athletes among 
the high responders (82.6%), moderate responders (50.0%) and 
non- or low responders (18.2%) (χ2=18.7, P < 0.0001). Similarly, 
when considering increases of Aero3 (%), we found a signiicant 
linear trend for the proportion of matched-trained athletes among 
the high (increase in Aero3 from 6.0 to 13.2%; n = 22) responders 
(86.4%), moderate (increase in Aero3 from 2.0 to 5.9%; n = 23) 
responders (47.8%) and non- or low (increase in Aero3 from -6.1 
to 1.9%; n = 22) responders (18.2%) (χ2=20.5, P < 0.0001). In 
other words, among non- or low responders to any type of resistance 
Group Increase in CMJ, % P1
Low-intensity RT P2 (paired test) High-intensity RT P2 (paired test)
Study 1
All athletes (n = 28) 6.4 (5.8) 0.0009* 4.1 (8.1) 0.131 0.369
Athletes with P genotype (n = 11) 3.8 (5.0) 0.156 7.0 (6.7) 0.125 0.429
Athletes with E genotype (n = 17) 8.2 (5.9) 0.0078* 2.2 (8.8) 0.813 0.067
P3 = 0.272 P3 = 0.353
Study 2
All athletes  (n = 39) 4.6 (4.3) 0.0056* 5.0 (4.7) <0.0001* 0.932
Athletes with P genotype (n = 17) 1.0 (4.6) 0.578 7.1 (5.9) 0.0059* 0.0046*
Athletes with E genotype (n = 22) 7.1 (1.0) 0.002* 3.2 (2.5) 0.0005* 0.0008*
P3 = 0.0002* P3 = 0.0056*
Studies 1 and 2
All athletes  (n = 67) 5.4 (5.0) <0.0001* 4.6 (6.1) 0.0002* 0.547
Athletes with P genotype (n = 28) 2.3 (4.8) 0.1465 7.1 (5.9) 0.0006* 0.0052*
Athletes with E genotype (n = 39) 7.6 (4.0) <0.0001* 2.8 (5.7) 0.051 0.0012*
P3 = 0.0022* P3 = 0.0098*
Note: *P < 0.05 - statistically different values between groups; P - power; E - endurance, RT - resistance training. P1 - comparison between athletes with different training types (i.e. low-intensity vs. high-intensity); P2 - signiicant increases in CMJ (paired test); P3 - comparison between athletes with different genotype proiles (i.e. power genotype vs. endurance genotype) of the same training modality
TABLE 3. Intergroup comparisons of CMJ increases (%) in response to high- or low-intensity training
Group Increase in Aero3, % P1
Low-intensity RT P2 (paired test) High-intensity RT P2 (paired test)
Study 1
All athletes (n = 28) 2.6 (3.1) 0.0103* 4.4 (4.4) 0.0017* 0.618
Athletes with P genotype (n = 11) 2.0 (4.3) 0.3125 6.0 (3.9) 0.0625 0.178
Athletes with E genotype (n = 17) 3.0 (2.2) 0.0078* 3.4 (4.6) 0.0391* 0.541
P3 = 0.776 P3 = 0.284
Study 2
All athletes  (n = 39) 5.8 (3.7) <0.0001* 4.2 (3.3) <0.0001* 0.218
Athletes with P genotype (n = 17) 1.7 (0.5) 0.0156* 6.8 (2.5) 0.002* 0.002*
Athletes with E genotype (n = 22) 8.7 (1.6) 0.002* 2.1 (2.3) 0.0161* <0.0001*
P3 = 0.0001* P3 = 0.002*
Studies 1 and 2
All athletes  (n = 67) 4.3 (3.8) <0.0001* 4.3 (3.7) <0.0001* 0.711
Athletes with P genotype (n = 28) 1.8 (2.8) 0.0171* 6.5 (2.9) <0.0001* 0.0004*
Athletes with E genotype (n = 39) 6.0 (3.5) <0.0001* 2.6 (3.3) 0.0004* 0.0013*
P3 = 0.0004* P3 = 0.0026*
Note: *P < 0.05 - statistically different values between groups; P - power; E - endurance, RT - resistance training. P1 - comparison between athletes with different training types (i.e. low-intensity vs. high-intensity); P2 - signiicant increases in Aero3 (paired test); P3 - comparison between athletes with different genotype proiles (i.e. power genotype vs. endurance genotype) of the same training modality 
TABLE 4. Intergroup comparisons of Aero3 increases (%) in response to high- or low-intensity training
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training, 82% of athletes (both for CMJ and Aero3) were from the 
mismatched group, while high responders were predominantly 
matched athletes (83% and 86% for CMJ and Aero3, respectively; 
P < 0.0001 for the comparison between non- or low responders and 
high responders). Accordingly, after 8 weeks of resistance training 
the odds of achieving more favorable outcomes in CMJ and Aero3 
were 21 and 28.5 times, respectively, greater (P < 0.0001) for 
matched than mismatched genotype training (when irst and third 
tertiles were compared). 
DISCUSSION 
To the best of our knowledge, this is the irst study to examine the 
eficacy of using genetic proiling methods to target training of both 
power and endurance qualities of athletes. The results of our study 
demonstrated that all performance parameters increased signii-
cantly in response to 8-weeks of either low- or high-intensity resistance 
training without differences between the two training modalities, 
however, the magnitude of training effects was strongly related to the 
association between genetic proile and training modality. Our main 
inding is that matching individual genotype with the appropriate 
mode of training led to more substantial resistance training beneits, 
for both power and endurance matched participants. More specii-
cally, in the irst athletes from the matched group demonstrated 
signiicantly enhanced results in explosive power and aerobic itness, 
while the gains realized by the mismatched athletes were of lesser 
magnitude. Importantly, these results were replicated in the second 
study, using a homogenous cohort of athletes. 
There was also a positive correlation between power genotype 
score of athletes and performance changes in response to high-in-
tensity training, as well as a positive correlation between endurance 
genotype score and increases in performance tests in response to 
low-intensity training: indings suggesting that the commonly observed 
heterogeneity in resistance training-induced explosive power and 
aerobic itness responses may be partly explained by genetic factors 
and selected training modalities. Another important inding was that 
among non- or low responders to resistance training, most athletes 
were from the mismatched group, while high responders were pre-
dominantly matched athletes. These results suggest personalized 
training prescription based on genetic proiling may help some indi-
viduals overcome unresponsiveness to resistance training.
Exercise training response is inluenced by a multitude of deter-
minants including genetics, environmental factors, measurement 
errors and others. Studies suggest that muscle strength and explosive 
power are under moderate to high genetic control with heritabilities 
ranging between 30 and 84% [17, 47]. Numerous studies reported 
the association between individual differences in strength/anaerobic 
power phenotypes in response to resistance/anaerobic power training 
and gene variations [16, 17]. Accordingly, several gene polymor-
phisms in our study were found to be individually linked with training 
responses. For instance, the II genotype of the ACE and XX (Ter/Ter) 
genotype of the ACTN3 genes (known as endurance markers) were 
associated (or tended to correlate) with increases in aerobic itness 
in response to low-intensity resistance training, while the ACE DD 
and ACTN3 RR (Arg/Arg) genotypes (known as power/strength mark-
ers) carriers demonstrated greater improvement of performance pa-
rameters in response to high-intensity resistance training, which is 
consistent with previous indings [48-51].
The likely mechanism through which the polygenic proile (i.e. 
proile composed of 15 polymorphisms) of athletes was associated 
with training responses could be the link between genetic variations 
and skeletal muscle characteristics, such as muscle ibre composition. 
Of note, 5 of 15 gene polymorphisms (ACE I/D, ACTN3 rs1815739 
C/T, PPARA rs4253778 G/C, PPARGC1A rs8192678 G/A and VEG-
FA rs2010963 G/C) included in our panel, have recently been re-
ported to be associated with muscle ibre type [18]. It is well known 
that slow-twitch muscle ibres better respond to low-intensity resis-
TABLE 5. Comparisons of CMJ and Aero3 increases (%) in response to resistance training between matched and mismatched groups. 
Study Group P3
Matched athletes Mismatched athletes
Study 1 n =14 P1 (paired test) n = 14 P2 (paired test)
Change in CMJ, % 7.8 (5.9) 0.0005* 2.9 (7.2) 0.175 0.0596
Change in Aero3, % 4.0 (3.1) 0.0004* 2.8 (4.3) 0.0134* 0.2456
Study 2 n =20 n = 19
Change in CMJ, % 7.1 (4.1) <0.0001* 2.4 (3.5) 0.0053* <0.0001*
Change in Aero3, % 7.7 (2.2) <0.0001* 1.9 (1.8) 0.0004* <0.0001*
Studies 1 and 2 n =34 n =33
Change in CMJ, % 7.4 (4.9) <0.0001* 2.6 (5.3) 0.0152* <0.0001*
Change in Aero3, % 6.2 (3.2) <0.0001* 2.3 (3.1) <0.0001* <0.0001*
Note: *P1 and P2 < 0.05 - signiicant increases in CMJ and Aero3 (paired test); *P3 < 0.05 - signiicant difference between matched and mismatched groups. Matched athletes - high-intensity trained with endurance genotype or low-intensity trained with power genotype; mismatched athletes - high-
intensity trained with power genotype or low-intensity trained with endurance genotype.
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CONCLUSIONS 
In conclusion, our results suggest that using genetic proiling to bet-
ter match individual genotype with appropriate training modality may 
be a powerful tool to aid more personalized, and precise, resistance 
training prescription in the future. 
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